1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Raibaud, S.
Lebars, I.
Bontems, F.
Dardel, F.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
323
143
10.1016/S0022-2836(02)00921-X
12368106
NMR Structure of Bacterial Ribosomal Protein L20: Implications for Ribosome Assembly and Translational Control
2002
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
6754.834
50S RIBOSOMAL PROTEIN L20
RESIDUES 59-118
1
man
polymer
no
no
WIARINAAVRAYGLNYSTFINGLKKAGIELDRKILADMAVRDPQAFEQVVNKVKEALQVQ
WIARINAAVRAYGLNYSTFINGLKKAGIELDRKILADMAVRDPQAFEQVVNKVKEALQVQ
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
VF5
sample
224324
AQUIFEX AEOLICUS
469008
ESCHERICHIA COLI
BL21(DE3)
PUBS520
PLASMID
PET11C
repository
Initial release
Version format compliance
Version format compliance
1
0
2002-05-10
1
1
2011-05-08
1
2
2011-07-13
PDBE
Y
PDBE
2002-05-02
REL
THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR SPECTROSCOPY ON 13C, 15N-LABELED L20. THE FIRST 58 RESIDUES ARE PRESENT IN THE SAMPLE BUT ARE DISORDERED IN SOLUTION
LOWEST DIANA TARGET FUNCTION
100
20
HNCA
NOESY-HMQC
TOCSY-HMQC
HCCH-TOCSY
NOESY
DQF-COSY
HNHA
HNHB
0.5
6.5
pH
1
atm
318
K
RESTRAINED SIMUATED ANNEALING FOLLOWED BY A FINAL MINIMIZATION USING THE CHARMM22 FORCEFIELD
HYBRID : DIANA FOLLOWED BY RESTRAINED SIMULATED ANNEALING
7
BRUNGER
refinement
X-PLOR
3.89
structure solution
DIANA
structure solution
XPLOR
600
Bruker
DRX
TRP
59
n
1
TRP
59
A
ILE
60
n
2
ILE
60
A
ALA
61
n
3
ALA
61
A
ARG
62
n
4
ARG
62
A
ILE
63
n
5
ILE
63
A
ASN
64
n
6
ASN
64
A
ALA
65
n
7
ALA
65
A
ALA
66
n
8
ALA
66
A
VAL
67
n
9
VAL
67
A
ARG
68
n
10
ARG
68
A
ALA
69
n
11
ALA
69
A
TYR
70
n
12
TYR
70
A
GLY
71
n
13
GLY
71
A
LEU
72
n
14
LEU
72
A
ASN
73
n
15
ASN
73
A
TYR
74
n
16
TYR
74
A
SER
75
n
17
SER
75
A
THR
76
n
18
THR
76
A
PHE
77
n
19
PHE
77
A
ILE
78
n
20
ILE
78
A
ASN
79
n
21
ASN
79
A
GLY
80
n
22
GLY
80
A
LEU
81
n
23
LEU
81
A
LYS
82
n
24
LYS
82
A
LYS
83
n
25
LYS
83
A
ALA
84
n
26
ALA
84
A
GLY
85
n
27
GLY
85
A
ILE
86
n
28
ILE
86
A
GLU
87
n
29
GLU
87
A
LEU
88
n
30
LEU
88
A
ASP
89
n
31
ASP
89
A
ARG
90
n
32
ARG
90
A
LYS
91
n
33
LYS
91
A
ILE
92
n
34
ILE
92
A
LEU
93
n
35
LEU
93
A
ALA
94
n
36
ALA
94
A
ASP
95
n
37
ASP
95
A
MET
96
n
38
MET
96
A
ALA
97
n
39
ALA
97
A
VAL
98
n
40
VAL
98
A
ARG
99
n
41
ARG
99
A
ASP
100
n
42
ASP
100
A
PRO
101
n
43
PRO
101
A
GLN
102
n
44
GLN
102
A
ALA
103
n
45
ALA
103
A
PHE
104
n
46
PHE
104
A
GLU
105
n
47
GLU
105
A
GLN
106
n
48
GLN
106
A
VAL
107
n
49
VAL
107
A
VAL
108
n
50
VAL
108
A
ASN
109
n
51
ASN
109
A
LYS
110
n
52
LYS
110
A
VAL
111
n
53
VAL
111
A
LYS
112
n
54
LYS
112
A
GLU
113
n
55
GLU
113
A
ALA
114
n
56
ALA
114
A
LEU
115
n
57
LEU
115
A
GLN
116
n
58
GLN
116
A
VAL
117
n
59
VAL
117
A
GLN
118
n
60
GLN
118
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
7
A
A
H
H
ASP
ARG
89
90
1.14
11
A
A
H
H
ARG
LYS
90
91
1.29
13
A
A
H3
H
TRP
ILE
59
60
1.22
14
A
A
H
H
VAL
GLN
117
118
1.19
18
A
A
H
H
ARG
LYS
90
91
1.34
1
A
A
LEU
GLN
115
116
-144.04
5
A
A
LEU
GLN
115
116
-145.47
7
A
A
LEU
GLN
115
116
-144.31
9
A
A
VAL
LYS
111
112
149.93
10
A
A
ASP
ARG
89
90
-145.01
13
A
A
ASP
ARG
89
90
111.56
18
A
A
LEU
GLN
115
116
-146.91
1
-3.65
0.60
121.00
117.35
A
A
A
CB
CG
CD2
TYR
TYR
TYR
74
74
74
N
1
3.68
0.60
121.00
124.68
A
A
A
CB
CG
CD1
TYR
TYR
TYR
74
74
74
N
3
-4.73
0.60
121.00
116.27
A
A
A
CB
CG
CD2
TYR
TYR
TYR
74
74
74
N
3
5.17
0.60
121.00
126.17
A
A
A
CB
CG
CD1
TYR
TYR
TYR
74
74
74
N
3
-12.42
1.90
110.20
97.78
A
A
A
CB
CA
C
LEU
LEU
LEU
93
93
93
N
5
4.28
0.70
120.80
125.08
A
A
A
CB
CG
CD1
PHE
PHE
PHE
77
77
77
N
9
20.25
1.90
113.70
133.95
A
A
A
CA
CB
CG
TRP
TRP
TRP
59
59
59
N
9
16.08
2.50
121.70
137.78
A
A
A
C
N
CA
ARG
LYS
LYS
90
91
91
Y
9
-11.50
1.90
110.20
98.70
A
A
A
CB
CA
C
LEU
LEU
LEU
93
93
93
N
10
-9.13
1.50
110.10
100.97
A
A
A
CB
CA
C
ALA
ALA
ALA
94
94
94
N
13
12.74
1.90
113.70
126.44
A
A
A
CA
CB
CG
TRP
TRP
TRP
59
59
59
N
13
-9.16
1.30
126.60
117.44
A
A
A
CB
CG
CD2
TRP
TRP
TRP
59
59
59
N
13
-10.78
1.40
110.10
99.32
A
A
A
N
CA
CB
ALA
ALA
ALA
94
94
94
N
15
-3.98
0.60
121.00
117.02
A
A
A
CB
CG
CD2
TYR
TYR
TYR
74
74
74
N
15
4.25
0.60
121.00
125.25
A
A
A
CB
CG
CD1
TYR
TYR
TYR
74
74
74
N
16
-10.51
1.50
110.10
99.59
A
A
A
CB
CA
C
ALA
ALA
ALA
94
94
94
N
17
-11.61
1.90
110.20
98.59
A
A
A
CB
CA
C
LEU
LEU
LEU
93
93
93
N
19
-11.72
1.90
110.20
98.48
A
A
A
CB
CA
C
LEU
LEU
LEU
81
81
81
N
1
A
ILE
60
-147.50
-61.03
1
A
TYR
74
84.80
-24.22
1
A
LEU
88
-127.94
-166.98
1
A
LYS
91
136.23
126.35
1
A
ILE
92
82.30
22.12
1
A
LEU
115
-100.30
-72.11
2
A
ILE
60
-154.49
-60.91
2
A
ALA
69
172.32
-45.86
2
A
TYR
74
91.00
-36.97
2
A
ARG
90
120.25
-33.51
2
A
LYS
91
-178.01
127.99
2
A
ILE
92
79.79
76.08
2
A
LEU
93
177.35
-35.04
2
A
LEU
115
-71.61
-77.24
2
A
VAL
117
81.07
40.74
3
A
ALA
61
71.46
-13.70
3
A
TYR
74
85.09
-27.13
3
A
ILE
86
-99.42
-64.86
3
A
ASP
89
-139.94
-141.91
3
A
ARG
90
76.79
-179.20
4
A
ILE
60
-152.39
-63.18
4
A
TYR
74
84.00
-28.66
4
A
ILE
86
-100.50
-62.85
4
A
GLU
87
32.04
71.67
4
A
ARG
90
101.69
-24.03
4
A
LYS
91
-175.52
118.87
4
A
ILE
92
78.46
81.81
4
A
LEU
93
176.13
-36.08
4
A
VAL
98
-91.07
-63.73
4
A
GLN
116
71.00
51.51
5
A
ILE
60
-148.49
44.89
5
A
TYR
74
96.16
-39.51
5
A
ILE
86
-106.10
-65.41
5
A
ARG
90
171.81
-38.26
5
A
LYS
91
169.08
131.92
5
A
ILE
92
70.18
78.04
5
A
LEU
93
169.54
-34.07
5
A
LEU
115
-103.80
-76.94
6
A
ILE
60
-160.05
-63.85
6
A
TYR
74
87.07
-21.48
6
A
ILE
86
-105.85
-70.88
6
A
ARG
90
89.96
-27.51
6
A
LYS
91
-178.57
118.67
6
A
ILE
92
79.50
82.41
6
A
LEU
93
167.80
-32.92
6
A
GLN
116
71.16
50.71
7
A
ILE
60
-147.57
-64.19
7
A
TYR
74
83.43
-25.57
7
A
ASP
89
174.33
2.57
7
A
ARG
90
-95.74
39.34
7
A
LYS
91
112.57
131.89
7
A
ILE
92
86.88
12.96
7
A
LEU
115
-102.76
-75.85
8
A
ILE
60
-141.50
-60.38
8
A
ARG
68
-86.88
31.71
8
A
TYR
74
82.12
-22.20
8
A
ILE
86
-98.09
-71.48
8
A
ARG
90
107.89
-26.77
8
A
LYS
91
177.52
132.07
8
A
ILE
92
85.53
14.92
9
A
ILE
60
-137.52
-58.90
9
A
ALA
69
175.91
-49.61
9
A
TYR
74
84.76
-26.63
9
A
LEU
88
-124.13
-166.70
9
A
ASP
89
48.99
164.56
9
A
ARG
90
95.44
66.76
9
A
LYS
91
43.73
73.61
9
A
ILE
92
-149.60
-48.14
9
A
VAL
111
-93.55
33.79
9
A
LEU
115
-71.60
-81.53
10
A
ILE
60
-131.07
-64.99
10
A
TYR
74
84.66
-26.69
10
A
ILE
86
-88.79
-72.88
10
A
ASP
89
-149.46
-51.22
10
A
LEU
93
-156.70
-36.99
11
A
ILE
60
-161.39
-62.08
11
A
TYR
74
81.15
-29.44
11
A
GLU
87
58.22
80.01
11
A
LEU
88
-121.05
-153.33
11
A
ASP
89
25.25
90.88
11
A
LYS
91
171.78
132.48
11
A
ILE
92
85.22
24.38
11
A
GLN
116
70.60
49.85
12
A
ILE
60
-148.51
-62.09
12
A
TYR
74
79.44
-28.81
12
A
LYS
91
126.65
126.21
12
A
ILE
92
81.18
82.45
12
A
LEU
93
179.08
-35.84
13
A
ILE
60
-138.26
-69.27
13
A
TYR
74
83.08
-19.04
13
A
ASP
89
161.99
131.51
13
A
ARG
90
179.38
80.52
13
A
LYS
91
76.11
61.35
13
A
ILE
92
-152.63
-33.75
13
A
ALA
94
-25.98
-47.12
14
A
ILE
60
-141.56
-77.44
14
A
TYR
74
83.10
-28.96
14
A
ARG
90
94.70
53.81
14
A
LYS
91
68.76
64.55
14
A
ILE
92
-158.70
-47.09
14
A
GLN
116
-157.86
-69.64
14
A
VAL
117
-162.33
-26.73
15
A
ILE
60
-147.47
-57.39
15
A
ALA
69
-179.57
-47.98
15
A
TYR
74
92.36
-22.87
15
A
LEU
88
-126.94
-161.26
15
A
LYS
91
165.74
137.99
15
A
ILE
92
86.97
4.89
15
A
VAL
98
-97.51
-62.73
15
A
ASP
100
-119.44
75.44
15
A
GLN
116
70.86
42.14
16
A
ILE
60
-149.10
-74.40
16
A
TYR
74
82.16
-26.83
16
A
ILE
86
-98.23
-66.91
16
A
LEU
88
-121.08
-127.72
16
A
ASP
89
73.41
-173.96
16
A
ARG
90
87.11
50.35
16
A
LYS
91
70.16
65.68
16
A
ILE
92
-159.38
-46.55
17
A
ILE
60
-141.03
-86.63
17
A
TYR
74
83.31
-15.01
17
A
ARG
90
-125.77
-168.88
17
A
GLN
116
71.48
36.87
18
A
ILE
60
-160.04
-65.02
18
A
TYR
74
82.54
-31.67
18
A
ILE
86
-111.44
-71.37
18
A
ARG
90
-148.19
-33.36
18
A
LYS
91
177.16
135.81
18
A
ILE
92
91.54
-3.19
19
A
ILE
60
-150.22
-56.28
19
A
TYR
74
85.56
-30.42
19
A
ILE
86
-103.18
-69.43
19
A
GLU
87
37.93
62.76
19
A
ARG
90
163.55
-29.65
19
A
LYS
91
-178.41
123.67
19
A
ILE
92
76.18
82.89
19
A
LEU
93
168.33
-33.64
20
A
ILE
60
-159.17
-76.21
20
A
ARG
68
-90.19
35.40
20
A
TYR
74
81.38
-28.03
20
A
GLU
87
22.46
76.65
20
A
LEU
88
-126.70
-135.42
20
A
ASP
89
70.10
96.44
20
A
ARG
90
-160.62
58.69
20
A
LYS
91
66.33
65.80
20
A
ILE
92
-151.07
-53.18
50S RIBOSOMAL PROTEIN L20
Bacterial ribosomal protein L20 from Aquifex aeolicus
1
N
N
A
ILE
60
A
ILE
2
HELX_P
A
ARG
68
A
ARG
10
1
1
9
A
TYR
74
A
TYR
16
HELX_P
A
GLY
85
A
GLY
27
1
2
12
A
LEU
93
A
LEU
35
HELX_P
A
ASP
100
A
ASP
42
1
3
8
A
ASP
100
A
ASP
42
HELX_P
A
LEU
115
A
LEU
57
1
4
16
RIBOSOMAL PROTEIN
RIBOSOMAL PROTEIN, RIBOSOME, PROTEIN SYNTHESIS, TRANSLATIONAL CONTROL, RRNA-BINDING
RL20_AQUAE
UNP
1
O67086
59
118
1GYZ
59
118
O67086
A
1
1
60
1
P 1